Brianna M. Brooks

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2”.

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.18.255877

N/A

0DataRank · unranked

30 citations

Paul Shinn, Zina Itkin, Richard T. Eastman, Robert Bostwick, Lynn Rasmussen +14 more

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2

Frontiers in Pharmacology(2021)10.3389/fphar.2020.592737

N/A

0DataRank · unranked

95 citations

Paul Shinn, Zina Itkin, Richard T. Eastman, Robert Bostwick, Lynn Rasmussen +14 more

Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1

Stem Cell Research(2021)10.1016/j.scr.2021.102447

N/A

0DataRank · unranked

4 citations

Manisha Pradhan, Yu‐Shan Cheng, Kirill Gorshkov, Atena Farkhondeh, Catherine Z. Chen +6 more

Generation of an induced pluripotent stem cell line (TRNDi030-A) from a patient with Farber disease carrying a homozygous p. Y36C (c. 107 A>G) mutation in ASAH1

Stem Cell Research(2021)10.1016/j.scr.2021.102387

N/A

0DataRank · unranked

2 citations

Charles D. Yeh, Jeanette Beers, Chengyu Liu, Yu‐Shan Cheng, Kirill Gorshkov +4 more